DigestRedComo funciona
Red
/
Empresas
St
No verificado

Stoke Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

72 Comunicados de prensa

Ver todos los comunicados de prensa
23/09/2026
Mercado laboral
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Stoke Therapeutics Appoints Bo Cumbo to its Board of Directors, Enhancing Commercial Expertise as the Company Advances Zorevunersen Development Toward Potential FDA Approval and Commercialization
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
16/09/2026
Salud
Medicina - Varios
Sanidad
Ciencia
Biotecnología
Mercado de valores
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
03/09/2026
Mercado laboral
Eventos
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
02/09/2026
Web y redes sociales
Eventos
Ferias y Congresos
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Sanidad
Salud
Farmacéutica
Stoke Therapeutics to Present at the Cantor Global Healthcare Conference
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
01/09/2026
Eventos
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
18/08/2026
Mercado de valores
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Higiene alimentaria
Medicina - Varios
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
05/08/2026
Eventos
Finanzas
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
Stoke Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
03/08/2026
Web y redes sociales
Telefonía
Mercado de valores
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Stoke Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Updates
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
27/07/2026
Mercado de valores
Finanzas
Web y redes sociales
Telefonía
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2026 Business and Financial Updates
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
16/07/2026
Mercado de valores
Salud
Higiene alimentaria
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0